When amyloid deposition and neuroinflammation occur, as in AD, reactive astrocytes and vascular smooth muscle cells markedly increase their expression of MMP14 which may then play a significant role in degrading soluble and deposited Aβ peptides [20]. This evidence concerns the gene MMP14 and Alzheimer disease.